Skip to main content
. 2025 Jan 2;15(1):51. doi: 10.3390/biom15010051
PCOS Polycystic ovary syndrome
NIH National Institutes of Health
AES Androgen Excess Society
CLD Chronic liver disease
NAFLD Nonalcoholic fatty liver disease
MR Mendelian randomization
NASH Nonalcoholic steatohepatitis
SHBG Sex hormone binding globulin
OS Oxidative stress
ROS Reactive oxygen species
GCs Granulosa cells
FF Follicular fluid
IR Insulin resistance
SOC3 Suppressor of cytokine signaling 3
CRP C-reactive protein
LH Luteinizing hormone
SNPs Single-nucleotide polymorphisms
BMI Body mass index
FGF-21 Fibroblast growth factor 21
HPS Hepassocin
HOMA-IR Homeostatic Model Assessment for Insulin Resistance
PCSK9i Proprotein convertase subtilisin/kexin type 9 inhibitor
DEG Differentially expressed genes
LDLR Low-density lipoprotein receptors
MAFLD Metabolic-associated fatty liver disease
PNPLA3 Patatin-like phospholipase domain-containing three genes
GLP-1 Glucagon-like peptide-1
MI Myo-inositol
GLP- 1RA Glucagon-like peptide-1 receptor agonist
DCI D-chiro-inositol
OCs Oral contraceptives
DHT Dihydrotestosterone
SiRNA Small interfering RNA
MiRNA MicroRNA
LncRNA Long non-coding RNA
CircRNA Circular RNA